CD8A and head and neck squamous cell carcinoma: Findings by Deng et al. highlighted the importance of LAG-3 in suppressing anti-tumour immune responses, whereby LAG-3 blockade reduced tumour growth, potentiated anti-tumour responses of CD8+ T cells and decreased the population of immunosuppressive cells in a murine model of head and neck squamous cell carcinoma [21].